Cerebrovasular imaging company iSchemaView has received the FDA nod for its latest product the RAPID CTA, a 3D imaging platform for computed tomogrpahy angiography (CTA). “Our goal is to provide ...
A strategy of routine coronary CT angiography (CTA) made little difference to treatment decisions or 1-year outcomes, compared with standard care, in intermediate- to high-risk patients with chest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results